Xeris Biopharma Holdings (XERS) EPS (Basic) (2020 - 2026)
Xeris Biopharma Holdings' (XERS) quarterly EPS (Basic) came in at $0.01 in Q1 2026, up 121.66% YoY from $0.01 in Q1 2025, and down 81.03% on a QoQ basis from $0.07 in Q4 2025.
Xeris Biopharma Holdings (XERS) EPS (Basic) (2020 - 2026) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 7 years of EPS (Basic) data on file, last reported at $0.01 in Q1 2026.
- Quarterly EPS (Basic) rose 121.66% year-over-year to $0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.07 (up 123.82% YoY) and the FY2025 annual result came in at $0.0, up 100.92% from the prior year.
- EPS (Basic) slipped to $0.01 in Q1 2026, from $0.07 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.07 in Q4 2025 to a low of -$0.25 in Q1 2022.
- A 5-year average of -$0.09 and a median of -$0.1 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) decreased 19.64% — and 2025, when it soared 298.28%.
- Tracing XERS's EPS (Basic) over 5 years: stood at -$0.1 in 2022, then slipped by 2.02% to -$0.1 in 2023, then jumped by 64.18% to -$0.03 in 2024, then soared by 298.28% to $0.07 in 2025, then sank by 81.03% to $0.01 in 2026.
- The last three EPS (Basic) figures came in at $0.01 (Q1 2026), $0.07 (Q4 2025), and $0.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -0.49 |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 2.07 |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.45 |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 7.82 |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -0.10 |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 1.43 |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.11 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.50 Bn | 1.38 Bn | 79.59 Mn | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.07 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | -0.01 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.03 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.10 |
| Sep 30, 2023 | -0.09 |
| Jun 30, 2023 | -0.14 |
| Mar 31, 2023 | -0.12 |
| Dec 31, 2022 | -0.10 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.19 |
| Mar 31, 2022 | -0.25 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.39 |